Evidence map›Paper›PMID 35247943›Full record

ArticleInternational journal of health policy and management2022

The Use of Evidence-Informed Deliberative Processes for Health Insurance Benefit Package Revision in Iran.

Mojtaba Nouhi, Rob Baltussen, Seyed Sajad Razavi, Leon Bijlmakers, Moahmmad Ali Sahraian, Zahra Goudarzi, Parisa Farokhian, Jamaleddin Khedmati, Reza Jahangiri, Alireza Olyaeemanesh

Abstract read
In one paragraph

Article in International journal of health policy and management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Healthcare priority-setting criteria and social values in Iran: an investigation of local evidence.International journal of technology assessment in health care · 2023
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mojtaba NouhiNational Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-4466-8403
Rob BaltussenRadboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0002-5982-8983
Seyed Sajad RazaviMofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Leon BijlmakersRadboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0003-2252-0579
Moahmmad Ali SahraianMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Zahra GoudarziHealth Human Resources Research Center, Department of Health Economics, School of Management and Medical Informatics, Shiraz University of Medical Sciences, Shiraz, Iran.
Parisa FarokhianHigh Council for Health Insurance, Ministry of Health and Medical Education, Tehran, Iran.
Jamaleddin KhedmatiPharmaceutical Management and Economics Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Reza JahangiriHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Alireza OlyaeemaneshHealth Equity Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-7417-2417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIran considers the revision of its health insurance benefit package (HIBP) as a means to achieve universal health coverage (UHC). Yet, its decision-making process has been criticised for being weak in terms of accountability and transparency. This paper reports on the development and implementation of the HIBP revision in Iran in the period 2019-2021, employing evidence-informed deliberative processes (EDPs), a framework for benefit package design with the explicit aim of optimising the legitimacy of decision-making.

methodsThe High Council for Health Insurance (HCHI) is coordinating the HIBP revision: it planned the six steps of the EDP framework with support from World Health Organization (WHO) and Radboudumc in 2019, and conducted a pilot project on multiple sclerosis (MS) diagnosis and treatment in 2020.

resultsImplementation of the MS pilot project concerned the installation of advisory committees (involving some 60 stakeholders in supportive task forces, a technical working group [TWG] and a national advisory committee [NAC]), the selection of decision criteria (relating to quality of care, necessity, and sustainability), the inclusion of services for evaluation (nine in total), and the assessment and appraisal of these services.

conclusionImplementation of the priority setting process for MS diagnosis and treatment services has likely improved the legitimacy of decision-making by involving stakeholders who engaged in deliberation based on available evidence in a stepwise, transparent process. It is expected to improve the quality of care for MS patients as well as its financial accessibility, at a zero net budget impact. The pilot project has served to help Iran's health system move faster toward UHC for a broader range of essential health services.

Indexed as

Insurance BenefitsInsurance, HealthHealth ServicesHumansIranPilot ProjectsBenefit PackageDeliberative ProcessesIranMultiple SclerosisRevisionUniversal Health Coverage

Identifiers

PMID35247943
PMCPMC9818091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.